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Dear Editor:
With interest we read the article by Ashrafi et al. about a
14-year-old female who is regarded to have developed Leigh
syndrome (LS) after traumatic brain injury (TBI) (1). We have
the following comments and concerns:
We do not agree with the notion that traumatic brain injury
was the precipitating factor for LS. The patient had a his-
tory of hypoacusis, which is a typical clinical manifestation
of a mitochondrial disorder (MID). Hypoacusis obviously
had developed long before the TBI. Additionally, the patient
was diagnosed with neuropathy of the peripheral nerves two
months after TBI. It is rather unlikely that neuropathy was
triggered by TBI and more likely it was already present before
the trauma. Thus, the initial manifestations of LS in the pre-
sented patient were most likely hypoacusis followed by neu-
ropathy and TBI only might have triggered the seizure but
not the MID. Why was the patient put on phenytoin, which
is well-known to be mitochondrion-toxic (2)? Phenytoin may
worsen epilepsy and MID in general and it is conceivable
that in fact phenytoin was responsible for worsening of the
phenotype and not the TBI. In a 16-year-old female with
MELAS syndrome due to the mutation m.3243A>G, pheny-
toin caused intestinal pseudo-obstruction one month after
intravenous phenytoin for status epilepticus (3). In a pa-
tient with Kearns-Sayre syndrome phenytoin decreased cere-
brospinal fluid (CSF) folate levels (4). In rat hepatocytes,
phenytoin increased reactive oxygen species (ROS) forma-
tion, decreased intracellular reduced glutathione, increased
intracellular oxidised glutathione, and enhanced lipid per-
oxidation and mitochondrial damage (5). In a hepatic mi-
crosomal system, phenytoin decreased state-3 respiration,
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ATP synthesis, and the mitochondrial membrane potential.
In this model, phenytoin increased state-4 respiration, im-
paired Ca++-uptake and release, and inhibited Ca++-induced
swelling (6). It would be interesting to know how the GJB2
mutation was detected. Was whole exome or panel sequenc-
ing carried out? Did the authors choose a gene by gene se-
quencing approach? Did the parents undergo genetic inves-
tigations? Did each of them carry the mutation in the het-
erozygous state? Did either of the parents manifest clinically?
We should be informed about the exact sequence of the TBI.
Is it conceivable that the fall was already due to a seizure or
syncope? Was the patient unconscious after the TBI? The au-
thors mention that basal ganglia lesions were “negative” on
DWI (1). However, basal ganglia appear hyperintense on DWI
in figure 2. What was the cause of respiratory insufficiency at
the second admission? Was it attributable to the cerebral le-
sions, to myopathy affecting the respiratory muscles, to lac-
tic acidosis, or to a pulmonary infection? Simultaneous ap-
plication of a bunch of drugs is not advisable since it cannot
be differentiated which of them is effective in case the ad-
ministration is followed by a beneficial response. Overall, the
report is not convincing with regard to TBI as the precipitat-
ing factor of LS. Most likely, worsening of LS was a random
event or triggered by phenytoin. It is also conceivable that
stress from TBI triggered the production of ROS, which were
mitochondrion-toxic to such a degree that a previously sub-
clinical condition became gradually symptomatic.
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